Yüklüyor......
The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India
CONTEXT: The guideline recommended dose of intravenous (i.v) recombinant tissue-type plasminogen activator (rt-PA) for acute ischemic stroke is 0.9 mg/kg in the European and American populations. In Asiatic population, some studies have shown that a lower dose of i.v rt-PA is equally efficacious. AI...
Kaydedildi:
| Yayımlandı: | Ann Indian Acad Neurol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341265/ https://ncbi.nlm.nih.gov/pubmed/28298840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-2327.199911 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|